The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Fisher and Sons Regulatory News (FSJ)

Share Price Information for James Fisher and Sons (FSJ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 304.00
Bid: 300.00
Ask: 309.00
Change: -6.00 (-1.94%)
Spread: 9.00 (3.00%)
Open: 300.00
High: 304.00
Low: 296.00
Prev. Close: 310.00
FSJ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

18 Aug 2009 07:00

RNS Number : 5866X
Fisher (James) & Sons PLC
18 August 2009
 



18 August 2009 

JAMES FISHER AND SONS PLC

Acquisition of MB Faber

James Fisher and Sons plc today announces the purchase of MB Faber Ltd (Faber) for up to £5.25 million in cash. The consideration consists of £4.0 million net of cash payable on completion with up to a further £1.25 million in March 2010, provided the EBITDA (earnings before interest tax depreciation and amortisation) for the year ended 31 December 2009, exceeds £1.225 million.

Faber provides specialist electrical and engineering services to the nuclear and aerospace industries. It will be integrated with James Fisher's existing nuclear decommissioning business, James Fisher Nuclear (JFN) which designs and builds remote handling devices for nuclear decommissioning. Faber is synergistic with JFN and will strengthen and give greater scale to James Fisher's existing nuclear decommissioning business.

Faber is based in Leyland, Lancashire, and has satellite operations close to Sellafield in Cumbria. It currently employs 120 specialist engineers and has been in the nuclear business since 1988. Its turnover in 2008 was £6.8 million with an EBITDA of £522,000 (after adjustment for nonrecurring items) and depreciation charge of £114,000. At 31 December 2008 it had net assets of £1.2 million.

Tim Harris, Chairman of James Fisher and Sons plc, said:

"Faber will strengthen our nuclear decommissioning team and business which has been performing strongly in recent times".

E C Hambro Rabben & Partners has acted as corporate adviser to James Fisher and Sons plc

Contacts:

James Fisher and Sons plc

Tim Harris

Chairman

020 7614 9508

James Fisher Nuclear

Paul Read

Managing Director

07831 553 719

EC Hambro Rabben & Partners

Eivind Rabben

Peter Donald

020 7355 4100

Financial Dynamics

Simon Elliott

020 7269 9318

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQFDLLFKVBEBBZ
Date   Source Headline
22nd Mar 20224:35 pmRNSHolding(s) in Company
10th Mar 20227:00 amRNSFull year results for the year ended 31 Dec 21
24th Jan 202210:54 amRNSDirector Declaration
29th Dec 20219:55 amRNSMozambique update
17th Dec 20217:00 amRNSAppointment of non-executive director
15th Dec 20215:36 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Dec 20215:22 pmRNSHolding(s) in Company
18th Nov 202110:25 amRNSHolding(s) in Company
2nd Nov 20217:00 amRNSSale of James Fisher Testing Services for £5.7m
1st Nov 20215:23 pmRNSDirector/PDMR Shareholding
25th Oct 20217:00 amRNSTrading update
22nd Oct 20218:00 amRNSAppointment of non-executive director
15th Sep 20211:26 pmRNSDirector/PDMR Shareholding
7th Sep 20217:00 amRNSHalf year results for the 6 months ended 30 Jun 21
1st Jul 20217:00 amRNSSale of Paladin for US$17.3m
29th Jun 20217:00 amRNSCapital Markets Event & Pre Close Trading Update
15th Jun 20213:51 pmRNSBLOCK LISTING SIX MONTHLY RETURN
2nd Jun 20214:16 pmRNSDirector/PDMR Shareholding
30th Apr 202111:59 amRNSDirector Declaration
29th Apr 20212:01 pmRNSResult of Annual General Meeting
29th Apr 20217:00 amRNSAGM Trading Statement
20th Apr 20217:00 amRNSAppointment of Chief Financial Officer
13th Apr 202111:32 amRNSWithdrawal of Annual General Meeting Resolution
9th Apr 202110:18 amRNSDirector/PDMR Shareholding
8th Apr 20213:58 pmRNSDirector/PDMR Shareholding
6th Apr 20213:48 pmRNSDirector/PDMR Shareholding
1st Apr 20217:00 amRNSTotal Voting Rights and Share Capital
29th Mar 20217:00 amRNSDirectorate Change
23rd Mar 202112:58 pmRNSAnnual Report and Notice of AGM posted
19th Mar 20211:17 pmRNSHolding(s) in Company
11th Mar 20217:00 amRNSResults for the year ended 31 December 2020
25th Feb 202110:42 amRNSNotification of FY Results Date
25th Jan 20217:00 amRNSAngus Cockburn appointed as Chairman
7th Jan 20217:00 amRNSPost close trading update
18th Dec 20204:41 pmRNSSecond Price Monitoring Extn
18th Dec 20204:35 pmRNSPrice Monitoring Extension
15th Dec 202011:18 amRNSBLOCK LISTING SIX MONTHLY RETURN
11th Nov 20207:00 amRNSDirector/PDMR Shareholding
9th Nov 20205:25 pmRNSTotal Voting Rights
6th Nov 20207:00 amRNSTrading Update
2nd Nov 20207:00 amRNSTotal Voting Rights
23rd Oct 20209:48 amRNSDirector/PDMR Shareholding
6th Oct 20203:58 pmRNSDirector/PDMR Shareholding
2nd Oct 20207:00 amRNSRoyal Navy contract award
21st Sep 20204:00 pmRNSDirector/PDMR Shareholding
25th Aug 20207:00 amRNSHalf-year results
24th Jul 202012:00 pmRNSDirector/PDMR Shareholding
7th Jul 20207:00 amRNSHalf year post close trading update
24th Jun 202012:02 pmRNSPrice Monitoring Extension
15th Jun 20207:00 amRNSBLOCK LISTING SIX MONTHLY RETURN

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.